Ibáñez, Borja2020-04-082020-04-082020-02-14Eur Heart J. 2020; 51(7):855-70195-668Xhttp://hdl.handle.net/20.500.12105/9470This editorial refers to ‘16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction’†, by P.G. Thrane et al.engAMhttp://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 Internacional31605481417855-85710.1093/eurheartj/ehz7161522-9645European heart journalopen access